RISS 학술연구정보서비스

검색
다국어 입력

http://chineseinput.net/에서 pinyin(병음)방식으로 중국어를 변환할 수 있습니다.

변환된 중국어를 복사하여 사용하시면 됩니다.

예시)
  • 中文 을 입력하시려면 zhongwen을 입력하시고 space를누르시면됩니다.
  • 北京 을 입력하시려면 beijing을 입력하시고 space를 누르시면 됩니다.
닫기
    인기검색어 순위 펼치기

    RISS 인기검색어

      KCI등재

      No Association Study of SLC6A4 Polymorphisms with Korean Autism Spectrum Disorder

      한글로보기

      https://www.riss.kr/link?id=A101640595

      • 0

        상세조회
      • 0

        다운로드
      서지정보 열기
      • 내보내기
      • 내책장담기
      • 공유하기
      • 오류접수

      부가정보

      다국어 초록 (Multilingual Abstract)

      Objectives : The serotonin transporter gene(SLC6A4) is one of the most widely studied candidate genes in autism spectrum disorder(ASD), but there have been conflicting results from studies into the association between SLC6A4 and ASD. The aim of this s...

      Objectives : The serotonin transporter gene(SLC6A4) is one of the most widely studied candidate genes in autism spectrum disorder(ASD), but there have been conflicting results from studies into the association between SLC6A4 and ASD. The aim of this study was to evaluate the association between single nucleotide polymorphisms(SNPs) in the SLC6A4 gene and ASD in the Korean population. Methods : We selected 12 SNPs in SLC6A4 and observed the genotype of 151 Korean ASD trios. We tested the family-based association for each individual polymorphism and haplotype by using the standard TDT method in Haploview(http://www.broad.mit.edu/mpg/haploview/). Results : Through transmission-disequilibrium testing and haplotype analysis, we could not find any statistically significant transmitted allele or haplotype. In addition, a case-control association test with Korean HapMap data did not reveal any statistical significance. Conclusion : Although serotonin-related genes must be considered candidate genes for ASD, we suggest that common SNPs of SLC6A4 are not important markers for associations with Korean ASD.

      더보기

      참고문헌 (Reference)

      1 Coutinho AM, "Variants of the serotonin transporter gene (SLC6A4) significantly contribute to hyperserotonemia in autism" 9 : 264-271, 2004

      2 Kim SJ, "Transmission disequilibrium mapping at the serotonin transporter gene (SLC6A4) region in autistic disorder" 7 : 278-288, 2002

      3 Cook EH, "The serotonin system in autism" 8 : 348-354, 1996

      4 Persico AM, "Serotonin transporter gene promoter variants do not explain the hyperserotoninemia in autistic children" 7 : 795-800, 2002

      5 Betancur C, "Serotonin transporter gene polymorphisms and hyperserotoninemia in autistic disorder" 7 : 67-71, 2002

      6 Conroy J, "Serotonin transporter gene and autism: a haplotype analysis in an Irish autistic population" 9 : 587-593, 2004

      7 Lange C, "Power and design considerations for a general class of family-based association tests: quantitative traits" 71 : 1330-1341, 2002

      8 Veenstra-VanderWeele J, "Pharmacogenetics and the serotonin system: initial studies and future directions" 410 : 165-181, 2000

      9 Cross S, "Molecular genetics of the platelet serotonin system in first-degree relatives of patients with autism" 33 : 353-360, 2008

      10 Jones MB, "Modifier effects in autism at the MAO-A and DBH loci" 126 : 58-65, 2004

      1 Coutinho AM, "Variants of the serotonin transporter gene (SLC6A4) significantly contribute to hyperserotonemia in autism" 9 : 264-271, 2004

      2 Kim SJ, "Transmission disequilibrium mapping at the serotonin transporter gene (SLC6A4) region in autistic disorder" 7 : 278-288, 2002

      3 Cook EH, "The serotonin system in autism" 8 : 348-354, 1996

      4 Persico AM, "Serotonin transporter gene promoter variants do not explain the hyperserotoninemia in autistic children" 7 : 795-800, 2002

      5 Betancur C, "Serotonin transporter gene polymorphisms and hyperserotoninemia in autistic disorder" 7 : 67-71, 2002

      6 Conroy J, "Serotonin transporter gene and autism: a haplotype analysis in an Irish autistic population" 9 : 587-593, 2004

      7 Lange C, "Power and design considerations for a general class of family-based association tests: quantitative traits" 71 : 1330-1341, 2002

      8 Veenstra-VanderWeele J, "Pharmacogenetics and the serotonin system: initial studies and future directions" 410 : 165-181, 2000

      9 Cross S, "Molecular genetics of the platelet serotonin system in first-degree relatives of patients with autism" 33 : 353-360, 2008

      10 Jones MB, "Modifier effects in autism at the MAO-A and DBH loci" 126 : 58-65, 2004

      11 McCauley JL, "Linkage and association analysis at the serotonin transporter (SLC6A4) locus in a rigid-compulsive subset of autism" 127 : 104-112, 2004

      12 Ramoz N, "Lack of evidence for association of the serotonin transporter gene SLC6A4 with autism" 60 : 186-191, 2006

      13 Wu S, "Lack of evidence for association between the serotonin transporter gene (SLC6A4) polymorphisms and autism in the Chinese trios" 381 : 1-5, 2005

      14 Persico AM, "Lack of association between serotonin transporter gene promoter variants and autistic disorder in two ethnically distinct samples" 96 : 123-127, 2000

      15 Yoo HJ, "Korean version of Autism Diagnostic Observation Schedule (ADOS)" Hakji-sa 2007

      16 Yoo HJ, "Korean version of Autism Diagnostic Interview - Revised (ADI-R)" Hakji-sa 2007

      17 Anderson GM, "Genetics of childhood disorders: XLV. Autism, part 4: serotonin in autism" 4 : 1513-1516, 2002

      18 Cho IH, "Family-based association study of 5-HTTLPR and the 5-HT2A receptor gene polymorphisms with autism spectrum disorder in Korean trios" 1139 : 34-41, 2007

      19 Yirmiya N, "Evidence for an association with the serotonin transporter promoter region polymorphism and autism" 105 : 381-386, 2001

      20 Abramson RK, "Elevated blood serotonin in autistic probands and their first-degree relatives" 19 : 397-407, 1989

      21 Anderson GM, "Cohen DJ, Volkmar FR, Hoder EL, McPhedran P, et al. Whole blood serotonin in autistic and normal subjects" 28 : 885-900, 1987

      22 Bailey A, "Autism as a strongly genetic disorder: evidence from a British twin study" 25 : 63-77, 1995

      23 Lesch KP, "Association of anxiety-related traits with a polymorphism in the serotonin transporter gene regulatory region" 274 : 1527-1531, 1996

      24 Yoo HJ, "Association between PTGS2 polymorphism and autism spectrum disorders in Korean trios" 62 : 66-69, 2008

      25 "A genomewide screen of 345 families for autism-susceptibility loci" 73 : 886-897, 2003

      26 International Molecular Genetic Study of Autism Consortium, "A genomewide screen for autism: strong evidence for linkage to chromosomes 2q, 7q, and 16p" 69 : 570-581, 2001

      27 McDougle CJ, "A double-blind, placebo-controlled study of fluvoxamine in adults with autistic disorder" 53 : 1001-1008, 1996

      28 Gordon CT, "A double-blind comparison of clomipramine, desipramine, and placebo in the treatment of autistic disorder" 50 : 441-447, 1993

      29 Zhong N, "5-HTTLPR variants not associated with autistic spectrum disorders" 2 : 129-131, 1999

      더보기

      분석정보

      View

      상세정보조회

      0

      Usage

      원문다운로드

      0

      대출신청

      0

      복사신청

      0

      EDDS신청

      0

      동일 주제 내 활용도 TOP

      더보기

      주제

      연도별 연구동향

      연도별 활용동향

      연관논문

      연구자 네트워크맵

      공동연구자 (7)

      유사연구자 (20) 활용도상위20명

      인용정보 인용지수 설명보기

      학술지 이력

      학술지 이력
      연월일 이력구분 이력상세 등재구분
      2026 평가예정 재인증평가 신청대상 (재인증)
      2020-01-01 평가 등재학술지 유지 (재인증) KCI등재
      2017-01-01 평가 등재학술지 유지 (계속평가) KCI등재
      2013-01-01 평가 등재 1차 FAIL (등재유지) KCI등재
      2010-01-01 평가 등재학술지 유지 (등재유지) KCI등재
      2007-01-01 평가 등재학술지 선정 (등재후보2차) KCI등재
      2006-01-01 평가 등재후보 1차 PASS (등재후보1차) KCI등재후보
      2004-01-01 평가 등재후보학술지 선정 (신규평가) KCI등재후보
      더보기

      학술지 인용정보

      학술지 인용정보
      기준연도 WOS-KCI 통합IF(2년) KCIF(2년) KCIF(3년)
      2016 0.19 0.19 0.19
      KCIF(4년) KCIF(5년) 중심성지수(3년) 즉시성지수
      0.14 0.15 0.475 0
      더보기

      이 자료와 함께 이용한 RISS 자료

      나만을 위한 추천자료

      해외이동버튼